Pharma Focus America: Big Data Analytics – A Revolution in the Pharmaceutical Industry Article Pharma Focus America: Big Data Analytics – A Revolution in the Pharmaceutical Industry In this panel discussion, our panelists will explore how big data analytics is reshaping drug…Certara2023年9月11日
Methods to Increase Signal Finding in Rare Disease Drug Development Blog 希少疾患治療薬開発におけるシグナル検出を増加させる方法 希少疾患の治療薬に関する規制状況は大きく変化しています。Gleaning from several…Certara2023年9月8日
The Inflation Reduction Act’s Impact on Drug Development for Rare Diseases Article インフレ削減法が希少疾患の医薬品開発に与える影響 Despite these wins for many patients, the new law is already impacting the discovery and…Certara2023年9月1日
RAPS Sponsored Webcast: Plain Language Summaries: Understanding the “Why” Behind the Regulations and Guidance On-Demand Webinar RAPS協賛Webcast: Plain Language Summaries: Understanding the “Why” Behind the Regulations and Guidance Plain language regulatory requirements have recently come into effect for the EU and UK. This…Certara2023年8月30日
Quantification of drug metabolising enzymes and transporter proteins in the paediatric duodenum via LC-MS/MS proteomics using a QconCAT technique Publication Quantification of drug metabolising enzymes and transporter proteins in the paediatric duodenum via LC-MS/MS proteomics using a QconCAT technique Characterising the small intestine absorptive membrane is essential to enable prediction of the systemic exposure…Certara2023年8月29日
Certara Launches v11.0 of SEND Explorer Announcement Certara Launches v11.0 of SEND Explorer Delivers advanced data analysis and visualization capabilities to support nonclinical scientists PRINCETON, N.J.— August 28,…Certara2023年8月28日
Payers’ reaction to the IRA’s Medicare Part D Redesign Blog Payers’ reaction to the IRA’s Medicare Part D Redesign On 2022年8月16日, President Biden signed the Inflation Reduction Act of 2022 (IRA) into…Certara2023年8月25日
AMCP Poster – A survey-based analysis of the determinants of management in traditionally unmanaged categories of oncology and rare diseases Poster AMCP Poster – A survey-based analysis of the determinants of management in traditionally unmanaged categories of oncology and rare diseases Certara2023年8月25日
Development and Verification of a Japanese Pediatric Physiologically Based Pharmacokinetic Model with Emphasis on Drugs Eliminated by Cytochrome P450 or Renal Excretion Publication Development and Verification of a Japanese Pediatric Physiologically Based Pharmacokinetic Model with Emphasis on Drugs Eliminated by Cytochrome P450 or Renal Excretion Physiologically based pharmacokinetic (PBPK) models are useful in bridging drug exposure in different ethnic groups,…Certara2023年8月21日
Development and application of a PBPK modeling strategy to support antimalarial drug development Publication Development and application of a PBPK modeling strategy to support antimalarial drug development As part of a collaboration between Medicines for Malaria Venture (MMV), Certara UK and Monash…Certara2023年8月18日